HB 263·OH·house
Cap cost sharing for prescription insulin drugs, diabetes devices
In CommitteeFiled May 13, 2025
Sponsor: Munira Abdullahi
Latest Action
Refer to Committee
May 14, 2025
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Ask about HB 263
3 free questions a day, no accountHearings
- House Health: H. B. No. 12, H. B. No. 207, H. B. No. 263, H. B. No. 324, H. B. No. 162, H. B. No. 52House Health · Jun 11, 2025
- House Health: H. B. No. 12, H. B. No. 207, H. B. No. 52, H. B. No. 257, H. B. No. 263House Health · Jun 4, 2025
History
- Referred to committee
- Introduced
Sponsors
- Munira Abdullahi · sponsor
- Anita Somani
- Beryl Piccolantonio
- Bride Rose Sweeney
- Christine Cockley
- Crystal Lett
- Dani Isaacsohn
- Daniel P. Troy
- Darnell T. Brewer
- Derrick Hall
- Eric Synenberg
- Erika White
- Ismail Mohamed
- Joseph A. Miller, III
- Juanita O. Brent
- Karen Brownlee
- Lauren McNally
- Michele Grim
- Rachel B. Baker
- Sean P. Brennan
- Thomas Hall
- Tristan Rader
- Veronica R. Sims
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 263 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 263 freeOr ask your AI assistant about HB 263 directly:
Add to Claude, ChatGPT or Cursor